Canada invests in research hubs to accelerate Canada’s vaccine and therapeutics production
by CM staff
These Canadian research hubs were selected through a two-step review process that assessed the scientific merit and strategic alignment of the hub proposals with the strategy.
OTTAWA — The Government of Canada is investing $10 million in support of the creation of five research hubs:
- CBRF PRAIRIE Hub, led by the University of Alberta
- Canada’s Immuno-Engineering and Biomanufacturing Hub, led by The University of British Columbia
- Eastern Canada Pandemic Preparedness Hub, led by the Université de Montréal
- Canadian Pandemic Preparedness Hub, led by the University of Ottawa and McMaster University
- Canadian Hub for Health Intelligence & Innovation in Infectious Diseases, led by the University of Toronto
This investment, made through Stage 1 of the integrated Canada Biomedical Research Fund (CBRF) and Biosciences Research Infrastructure Fund (BRIF) competition, will bolster research and talent development efforts led by the institutions, working in collaboration with their partners..
The multidisciplinary research hubs will accelerate the research and development of vaccines and therapeutics and diagnostics, while supporting training and development to expand the pipeline of skilled talent. The hubs will accelerate the translation of research into commercially viable products and processes.
“To continue to protect Canadians and to build a resilient biomanufacturing ecosystem, our government is taking every action possible to be equipped with the best tools,” said François-Philippe Champagne, Minister of Innovation, Science and Industry. “We’re proud to foster the research needed to produce cutting-edge discoveries and products in our very own labs that will help us build a stronger, more robust life sciences sector that responds to the needs of Canadians for decades to come.”
